Diuretics Cause Metabolic Alkalosis, Not Acidosis
Thiazide and loop diuretics (furosemide, bumetanide, chlorothiazide) cause hypokalemia and metabolic alkalosis, while potassium-sparing diuretics (spironolactone, amiloride, triamterene) can cause hyperkalemia and metabolic acidosis. 1
Mechanism of Alkalosis with Loop and Thiazide Diuretics
Loop diuretics (furosemide, bumetanide, torsemide) and thiazide diuretics work by:
- Increasing sodium delivery to distal tubules, where sodium is exchanged for potassium and hydrogen ions
- This process is potentiated by activation of the renin-angiotensin-aldosterone system 2
- Results in loss of potassium, chloride, and hydrogen ions, creating hypochloremic, hypokalemic metabolic alkalosis 3
The metabolic alkalosis from these diuretics can exacerbate CO2 retention in patients with chronic lung disease, making adequate potassium chloride supplementation essential 1.
Mechanism of Acidosis with Potassium-Sparing Diuretics
Potassium-sparing diuretics (spironolactone, amiloride, triamterene) work differently:
- Reduce potassium and proton excretion in the distal tubule 4
- Spironolactone specifically can produce metabolic acidosis 3
- Risk of hyperkalemia is markedly increased when combined with ACE inhibitors or ARBs 4, 5
Carbonic Anhydrase Inhibitors: The Exception
Acetazolamide is unique among diuretics:
- Causes metabolic acidosis with extended administration 6
- Can be used therapeutically to correct metabolic alkalosis caused by loop diuretics 4, 6, 7
- Produces alkaline diuresis but commonly induces symptomatic metabolic acidosis 3
Clinical Monitoring Requirements
Check electrolytes 2-4 weeks after initiating or titrating diuretic doses, then periodically 8, 5:
- Monitor for hypokalemia and metabolic alkalosis with thiazides and loop diuretics
- Monitor for hyperkalemia with potassium-sparing agents, especially when combined with ACE inhibitors/ARBs
- Watch for hyponatremia, particularly with thiazides 5
Management of Diuretic-Induced Alkalosis
When metabolic alkalosis develops from loop or thiazide diuretics 4, 9:
- Provide adequate potassium chloride supplementation - this is the primary treatment
- Consider adding amiloride to reduce potassium loss and improve diuresis while countering alkalosis
- Acetazolamide can help treat the metabolic alkalosis but is a weak diuretic 4, 6
- When ACE inhibitors or ARBs are used with loop diuretics, long-term potassium supplementation is frequently not needed and may be harmful 2
Critical Pitfall
Never combine potassium-sparing diuretics with ACE inhibitors/ARBs without close monitoring - this combination dramatically increases hyperkalemia risk, especially in patients with chronic kidney disease 4, 5. If used together, check potassium every 5-7 days until stable, then every 3-6 months 9.